Arbeitsgruppe Kopf-Hals-Tumoren - Studien
Fortgeschrittenes inoperables Kopf-Hals Plattenepithelkarzinom, 1st-line

AIO-assoziierte-Studie
www.clinicaltrials.gov zur Studie
  AIO-KHT-0120/ass: 2 ARM RANDOMIZED PHASE II TRIAL TO ASSESS THE FEASIBILITY AND EFFICACY OF A TREATMENT WITH DURVALUMAB (MEDI4736) A PDL1-INHIBITOR PLUS TREMELIMUMAB A CTLA-4- INHIBITOR IN COMBINATION WITH RADIOTHERAPY AND A TREATMENT WITH DURVALUMAB IN COMBINATION WITH RADIOTHERAPY AS FIRST-LINE THERAPY FOR PATIENTS WITH NON-RESECTABLE LOCALLY ADVANCED HPV NEGATIVE HNSCC – A COMPARISON WITH A HISTORICAL CONTROL GROUP (DURTRERAD)
  ---in Rekrutierung---
operable Kopf-Hals Tumoren

AIO-assoziierte-Studie
www.clinicaltrials.gov zur Studie
  AIO-KHT-0220/ass: Window of opportunity study of preoperative immunotherapy with atezolizumab (Tecentriq®) or FAP-interleukin 2v (IL2v) (RO6874281) in local squamous cell carcinoma of the head and neck – an imCORE Study (PIONEER)
  ---in Vorbereitung---
LETZTE AKTUALISIERUNG DIESER SEITE AM: 29.11.2020